These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Encephalopathy and rhabdomyolysis induced by iotrolan during epiduroscopy. Mizuno J, Gauss T, Suzuki M, Hayashida M, Arita H, Hanaoka K. Can J Anaesth; 2007 Jan; 54(1):49-53. PubMed ID: 17197468 [Abstract] [Full Text] [Related]
25. Absence of postmyelographic adverse effects and high radiographic resolution of iotrolan used in the cervical myelography for the clinically normal cat: an open-placebo controlled study. Patsikas MN, Polizopoulou Z, Koutinas A, Galatos A, Moustardas N, Tzegas S, Dessiris A. Zentralbl Veterinarmed A; 1999 Mar; 46(2):69-74. PubMed ID: 10216443 [Abstract] [Full Text] [Related]
28. [The new nonionic contrast preparation for myelography iotrolan]. Sviridov NK. Zh Vopr Neirokhir Im N N Burdenko; 1994 Dec; (2):35-6. PubMed ID: 8209595 [No Abstract] [Full Text] [Related]
36. [Experimental studies on the elimination and neurotoxicity of a new water soluble contrast medium for lumbosacral myelography]. Braband H, Lessmann HD, Wenker H. Radiologe; 1972 Feb; 12(2):66-8. PubMed ID: 5027901 [No Abstract] [Full Text] [Related]
39. [Comments on the article by B. Maier et al. Iotrolan versus Iopamidol. A controlled double-blind study in lumbar myelography]. Maier B. Radiologe; 1993 Jan; 33(1):59. PubMed ID: 8441809 [No Abstract] [Full Text] [Related]
40. A possible role for cysteinyl-leukotrienes in non-ionic contrast media induced adverse reactions. Böhm I, Speck U, Schild H. Eur J Radiol; 2005 Sep; 55(3):431-6. PubMed ID: 16129253 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]